Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
VaxThera Chikungunya vaccine
- Development stage
- Approved
- Lead developer
- VaxThera
- Modality
- Viral Vectors → Gene Addition/Replacement → Gene Therapies, mRNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
VaxThera Chikungunya vaccine is an experimental prophylactic vaccine candidate currently in preclinical development by the Colombian biotechnology company VaxThera. The program utilizes both mRNA and viral vector platforms to induce protective immunity against the Chikungunya virus (CHIKV). This project is being developed in collaboration with the University of Wisconsin and the Universidad Nacional de Colombia, with co-funding from the Colombian Ministry of Science, Technology, and Innovation (Ministerio de Ciencia, Tecnología e Innovación). While VaxThera has entered into agreements with Valneva to commercialize and potentially manufacture the approved live-attenuated vaccine Ixchiq in Latin America, this specific pipeline candidate represents an independent, next-generation approach using different technological modalities.
- Other names
- Ixchiq-VaxThera-viral vector-mRNA-ChikungunyaVaxThera Chikungunya Vaccine
Beyond the preview
Go deeper on VaxThera Chikungunya vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on VaxThera Chikungunya vaccine.